Health Care & Life Sciences » Pharmaceuticals | Grape King Bio Ltd.

Grape King Bio Ltd. | Ownership

Companies that own Grape King Bio Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Fubon Life Insurance Co., Ltd.
9,300,000
6.86%
0
0.92%
03/31/2018
The Vanguard Group, Inc.
3,501,039
2.58%
20,000
0%
07/31/2018
Dimensional Fund Advisors LP
1,985,076
1.46%
49,141
0%
04/30/2018
Fidelity Management & Research Co.
1,748,000
1.29%
0
0%
04/30/2018
Swedbank Robur Fonder AB
1,661,000
1.23%
0
0.02%
07/31/2018
Norges Bank Investment Management
1,493,999
1.1%
535,961
0%
12/31/2017
Allianz Global Investors Taiwan Ltd.
1,258,800
0.93%
101,802
0.67%
03/31/2018
Yuanta Securities Investment Trust Co., Ltd.
1,236,074
0.91%
1,236,074
0.28%
03/31/2018
BC Investment Management Corp.
1,153,000
0.85%
132,000
0.02%
03/31/2017
BlackRock Fund Advisors
1,083,000
0.8%
0
0%
09/05/2018

About Grape King Bio

View Profile
Address
No. 402, Section 2 Jinling Road
Taoyuan 324
Taiwan
Employees -
Website http://www.grapeking.com.tw
Updated 07/08/2019
Grape King Bio Ltd. engages in the manufacture and sale of health food products. It focuses on the mushroom mycelium and probiotics. Its business activities include preparation of pharmaceutical products, medicines, and raw materials; as well as the manufacture and trade of medical equipment.